AI News NQ Analysis

Taizong Biotech: Announcement Regarding Termination of OTC Trading and Listing on Taiwan Stock Exchange

NQ Score 0/100
N1 Content Completeness 0

AI Summary (NQ-processed)

Taizong Biotech announced that its stock will terminate OTC trading and be listed on the Taiwan Stock Exchange starting April 8, 115. The company is also conducting a cash capital increase prior to its IPO.

AI Analysis

Frequently Asked Questions

Q: When will Taizong Biotech's stock terminate trading on the OTC market?
A: Taizong Biotech's stock is scheduled to terminate OTC trading on April 8, 2026.
Q: Where will Taizong Biotech be listed?
A: Taizong Biotech will be listed on the Taiwan Stock Exchange.
Q: Why is Taizong Biotech going public?
A: To facilitate the initial public offering and capital increase through cash subscription, and to enter a broader capital market.